跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag - TGA Drug Approval Details
Approvals
/
TGA
/
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag
Approved
STANDARD
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
b01eaacba413fd81
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b01eaacba413fd81
Product Name
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag
Artg Id
52395
Artg Name
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1996-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/819ae343c6bbcf934f972ef2be97dec9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3d5a80635b5afe13140a07ec2ccfdc29.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
b01eaacba413fd81
Type
Standard
Back to TGA Approvals